NEW STUDY ON BIODERMOGENESI® IN BIOMEDICAL JOURNAL

Once again, Biodermogenesi® (VEMF Therapy) has proven its efficacy and safety, this time in Dupuytren’s Contracture, a pathology that usually occurs in male patients over 40 years of age, which results in a motor deficit on some fingers, leading to reduced functionality of the hand.

This new major study was published in Biomedical Journal of Scientific & Technical Research and underlines that the patients who underwent between three and seven VEMF treatment sessions, have shown a significant improvement in every measurement and no side effects were found.

We would like to thank Simona Laura, Chiara Giorgio, Flavia Lupo and Carlo Zannella for their valuable support on the article.